blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3185907

EP3185907 - THERAPEUTIC APAC MOLECULE COMPRISING HEPARIN CONJUGATED TO A PLASMA PROTEIN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.08.2019
Database last updated on 18.01.2025
FormerThe patent has been granted
Status updated on  31.08.2018
FormerGrant of patent is intended
Status updated on  02.07.2018
FormerRequest for examination was made
Status updated on  02.06.2017
FormerThe international publication has been made
Status updated on  27.02.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Aplagon OY
Biomedicum Helsinki 2B
Tukholmankatu 8 B
00290 Helsinki / FI
[2017/27]
Inventor(s)01 / LASSILA, Riitta
c/o Aplagon Oy
Biomedicum Helsinki 2B
Tukholmankatu 8 B
FI-00290 Helsinki / FI
 [2017/27]
Representative(s)Myint, Julie Marie
Symbiosis IP Limited
Basepoint Business Centre
Vale Business Park
Crab Apple Way, Evesham
Worcestershire WR11 1GP / GB
[2018/40]
Former [2017/27]Fyles, Julie Marie
Symbiosis IP Limited
Basepoint Business Centre
Vale Business Park
Crab Apple Way, Evesham
Worcestershire WR11 1GP / GB
Application number, filing date15763504.624.08.2015
[2017/27]
WO2015EP69327
Priority number, dateGB2014001506226.08.2014         Original published format: GB 201415062
GB2015001063717.06.2015         Original published format: GB 201510637
[2017/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016030316
Date:03.03.2016
Language:EN
[2016/09]
Type: A1 Application with search report 
No.:EP3185907
Date:05.07.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 03.03.2016 takes the place of the publication of the European patent application.
[2017/27]
Type: B1 Patent specification 
No.:EP3185907
Date:03.10.2018
Language:EN
[2018/40]
Search report(s)International search report - published on:EP03.03.2016
ClassificationIPC:A61K47/50
[2017/27]
CPC:
A61K38/385 (EP,US); A61K31/727 (RU); A61K47/64 (EP,KR,US);
A61K38/36 (RU); A61K38/38 (RU); A61K47/61 (EP,RU,US);
A61K47/643 (EP,KR,RU,US); A61P13/12 (EP); A61P7/02 (EP,RU);
A61P9/00 (EP); A61P9/10 (EP); C07K14/765 (RU);
C08B37/0075 (RU) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/27]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:THERAPEUTISCHES APAC-MOLEKÜL MIT AN EIN PLASMAPROTEIN KONJUGIERTEM HEPARIN[2017/27]
English:THERAPEUTIC APAC MOLECULE COMPRISING HEPARIN CONJUGATED TO A PLASMA PROTEIN[2017/27]
French:MOLÉCULE APAC THÉRAPEUTIQUE COMPRENANT DE L'HÉPARINE CONJUGUÉE À UNE PROTÉINE PLASMATIQUE[2017/27]
Entry into regional phase27.02.2017National basic fee paid 
27.02.2017Designation fee(s) paid 
27.02.2017Examination fee paid 
Examination procedure25.02.2016Request for preliminary examination filed
International Preliminary Examining Authority: EP
27.02.2017Examination requested  [2017/27]
27.02.2017Date on which the examining division has become responsible
03.07.2018Communication of intention to grant the patent
20.08.2018Fee for grant paid
20.08.2018Fee for publishing/printing paid
20.08.2018Receipt of the translation of the claim(s)
Opposition(s)04.07.2019No opposition filed within time limit [2019/37]
Fees paidRenewal fee
27.06.2017Renewal fee patent year 03
25.06.2018Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU24.08.2015
AL03.10.2018
CY03.10.2018
CZ03.10.2018
EE03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
MK03.10.2018
MT03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
[2022/31]
Former [2021/34]HU24.08.2015
AL03.10.2018
CY03.10.2018
CZ03.10.2018
EE03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
MT03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2021/32]HU24.08.2015
AL03.10.2018
CY03.10.2018
CZ03.10.2018
EE03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2021/26]AL03.10.2018
CY03.10.2018
CZ03.10.2018
EE03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2020/25]AL03.10.2018
CZ03.10.2018
EE03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2019/50]AL03.10.2018
CZ03.10.2018
EE03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2019/40]AL03.10.2018
CZ03.10.2018
EE03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
RO03.10.2018
RS03.10.2018
SK03.10.2018
SM03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2019/37]AL03.10.2018
CZ03.10.2018
EE03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
RO03.10.2018
RS03.10.2018
SM03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2019/26]AL03.10.2018
CZ03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
RS03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2019/25]CZ03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
RS03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
Former [2019/24]CZ03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
BG03.01.2019
GR04.01.2019
IS03.02.2019
Former [2019/23]CZ03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
BG03.01.2019
IS03.02.2019
Former [2019/22]CZ03.10.2018
LT03.10.2018
BG03.01.2019
IS03.02.2019
Former [2019/21]LT03.10.2018
IS03.02.2019
Former [2019/20]LT03.10.2018
Cited inInternational search[A]US4526714  (FEIJEN JAN [NL], et al) [A] 1-9,12,21,32-36 * column 1, lines 36-51; example II; claims 1,4,12,13 * * column 2, lines 31-56 * * column 3, lines 6-16 *;
 [XDI]WO9926983  (JENNY JA ANTTI WIHURIN RAHASTO [FI], et al) [XD] 1-3,5-13,17,20-23,26-29,32-34,36,37,39 * page 5, lines 1-3, paragraph 4 * * page 7, lines 4-5 * * page 14, lines 3-5, paragraph 3 * * page 32, lines 4-7; example 1D * * page 32, line 1, paragraphs 2,3; examples 1E, 22 * * claims 1,7-12,20-22,24,27,29 * * page 7, lines 10-16, paragraph 1 * * page 7, lines 6-11, paragraph 2 * * page 8, paragraph 4 * * page 8, lines 1-3, paragraph 5 * * page 9, lines 1-3, paragraph 3 * * page 14, lines 3-6, paragraph 2 * * page 15, lines 2-5, paragraph 3 * * page 27, paragraphs 3-4 * [I] 1-13,16-23,26-41;
 [A]US6491965  (BERRY LESLIE [CA], et al) [A] 1-8,12,17,20-23,26,27,33-41 * column 9, lines 24-26; claims 1,11,13,14 * * column 9, lines 18-22 * * column 10, lines 19-24 * * column 7, lines 47-52 * * column 8, lines 22-24,55-57,60-64 *;
 [A]WO2009134054  (UNIV SOGANG IND UNIV COOP FOUN [KR], et al) [A] 30 * page 6; examples 1-1 *;
 [A]WO2013082196  (UNIV CALIFORNIA [US]) [A] 1,14-16,24,25* paragraph [0058] *;
 [A]WO2013095270  (CORLINE SYSTEMS AB [SE]) [A] 1,2,5-8,12,13,15,17,20-23,25-27,37-41 * page 7, lines 33-35; claims 1,4-11 * * page 4, line 24 - page 5, line 18 * * page 6, lines 1-9 * * page 2, lines 22-24 * * page 8; examples 4-6 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.